Breaking News

CHA Biotech Launches Global CDMO Biz

Matica Biotechnology to construct GMP facility for viral vector production in Texas.

By: Contract Pharma

Contract Pharma Staff

South Korea-based CHA Biotech has launched Matica Biotechnology, a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies. Plans call for a GMP production facility located in College Station, TX. Construction of the 25,000 square foot facility will begin in the fourth quarter this year and will be dedicated to the production of viral vectors used in cell and gene therapies, vaccines and oncolytic products. When...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters